Exchange Announcement • 01 Nov 2024 08:03
Exchange Announcement • 31 Oct 2024 07:47
Exchange Announcement • 30 Oct 2024 07:45
Exchange Announcement • 29 Oct 2024 17:31
Exchange Announcement • 28 Oct 2024 18:04
ENTITY
BeiGene (6160 HK)
BeiGene (6160 HK)
322
Analysis
Health Care • China
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
more
x